MCA
CVS icon

MSH Capital Advisors’s CVS Health CVS Stock Holding History

MSH Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,853
Closed -$218K – 232
2024
Q4 		$218K Sell
4,853
-22,217
-82% -$1.25M 0.07% 218
2024
Q3 		$1.7M Sell
27,070
-2,278
-8% -$133K 0.52% 62
2024
Q2 		$1.73M Buy
29,348
+586
+2% +$36.7K 0.58% 56
2024
Q1 		$2.29M Sell
28,762
-765
-3% -$58.4K 0.81% 35
2023
Q4 		$2.33M Sell
29,527
-149
-0.5% -$10.6K 0.87% 35
2023
Q3 		$2.07M Buy
29,676
+1,132
+4% +$80.2K 0.81% 37
2023
Q2 		$1.97M Buy
28,544
+228
+0.8% +$16.2K 0.72% 45
2023
Q1 		$2.1M Buy
28,316
+6,584
+30% +$552K 0.9% 31
2022
Q4 		$2.03M Buy
21,732
+363
+2% +$35K 0.92% 30
2022
Q3 		$2.04M Buy
21,369
+495
+2% +$49K 1% 25
2022
Q2 		$1.93M Buy
20,874
+319
+2% +$31.1K 0.9% 31
2022
Q1 		$2.08M Buy
20,555
+1,010
+5% +$106K 0.86% 36
2021
Q4 		$2.02M Buy
+19,545
New +$1.81M 0.9% 34

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

MSH Capital Advisors's CVS Position: Q1 2025 in Review

MSH Capital Advisors sold out of CVS Health (CVS) in Q1 2025, closing a stake of 4,853 shares — an estimated $218K sold.

MSH Capital Advisors first reported a position in CVS in Q4 2021 and held it in 13 quarters. The position peaked at $2.33M in Q4 2023. 1,756 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • MSH Capital Advisors reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • MSH Capital Advisors sold 4,853 CVS Health shares in Q1 2025, an estimated $218K.
  • MSH Capital Advisors first reported a position in CVS Health in Q4 2021 and held it in 13 quarters.
  • MSH Capital Advisors's CVS Health position peaked at $2.33M in Q4 2023.
  • 1,756 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on MSH Capital Advisors's 13F filing for Q1 2025, filed 13 May 2025.